Form 4: Teladoc Health CFO Mala Murthy Reports Stock Transactions

Mala Murthy, CFO of Teladoc Health, reports the acquisition and disposal of common stock and derivative securities, including performance stock units and restricted stock units, in a recent SEC Form 4 filing.

Summary

• Teladoc Health's CFO, Mala Murthy, filed a Form 4 with the SEC detailing changes in beneficial ownership of the company's stock.
• On March 1, 2024, Murthy acquired shares through the conversion of performance stock units and restricted stock units.
• Specifically, 10,565, 945, 1,878, 3,369, 2,044, 31,002, and 2,486 shares were acquired through these conversions.
• On March 4, 2024, Murthy disposed of 29,888 shares at a price of $14.516 per share to cover tax obligations related to the vesting of stock units.
• Following these transactions, Murthy directly owns 71,716 shares of Teladoc Health common stock.
• Murthy also holds derivative securities, including 31,696 performance stock units acquired on March 1, 2024, which vest over time.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

Form 4 filings are routine disclosures required by the SEC for corporate insiders, providing transparency into their trading activities. This filing indicates the CFO's transactions in Teladoc Health stock.

Stakeholder Impact

• Shareholders may be interested in the trading activity of company insiders as it can provide insights into management's perspective on the company's value.

Key Dates